Clearside Biomedical Inc (CLSD)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Nov 07, 16:00
1.11
0.00 (0.00%)
Pre-Market: 08:32
Clearside Biomedical Revenue (Annual): 8.226M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 8.226M |
December 31, 2022 | 1.327M |
December 31, 2021 | 29.58M |
December 31, 2020 | 7.894M |
Date | Value |
---|---|
December 31, 2019 | 2.173M |
December 31, 2018 | 0.03M |
December 31, 2017 | 0.345M |
December 31, 2016 | 0.52M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.327M
Minimum
2022
29.58M
Maximum
2021
9.839M
Average
7.894M
Median
2020
Revenue (Annual) Benchmarks
Viking Therapeutics Inc | -- |
Arcus Biosciences Inc | 117.00M |
Crinetics Pharmaceuticals Inc | 4.013M |
Biomea Fusion Inc | -- |
NovaBay Pharmaceuticals Inc | 14.73M |